Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants (NCT05285735)
🩺 Plain-English Summary (8th-Grade Level)
This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.
Who can join: Review the eligibility criteria below.
Location: 4C Pharma Solutions — Piscataway, New Jersey
Age range: 15 Years to 100 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- 4C Pharma Solutions — Piscataway, New Jersey
📞 Contact the Study Coordinator
Phone: (301) 762-2609
Email: kriggs@fastttrackresearch.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pregnancy
- Mother and Infant Home Visiting Program Evaluation — New York, New York
- Maternal Stress and Blood Sugar Metabolization — Sioux Falls, South Dakota
- Improving Maternal and Child Health Through Prenatal Fatty Acid Supplementation — Chicago, Illinois
- A Multimedia Presentation to Augment the Informed Consent Process for Anesthesia for Patients Undergoing Scheduled Caesarian Delivery — Chicago, Illinois
- Effects of Increased Maternal Choline Intake on Child Cognitive Development — Ithaca, New York
- Michigan Contraceptive Access, Research, and Evaluation Study: Phase 1 — Ann Arbor, Michigan
Explore by condition: All Pregnancy clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.